Herbal Supplement Market Size USD 8983.6 Million by 2026 at CAGR 3.3% - Valuates Reports
BANGALORE, India, Feb. 2, 2021 /PRNewswire/
Herbal Supplement Market is Segmented by Type (Mono - Herb Type, Multi - Herb Type), by Application (Pharmaceutical Industry, Health Care Industry), by Regions & Key players Regional Growth: Global Opportunity Analysis and Industry Forecast, 2021-2026. This report is published on
Valuates Reports in the
Nutrition Category.
The global Herbal Supplement Market size is projected to reach USD 8983.6 Million by 2026, from USD 7393.5 Million in 2020, at a CAGR of 3.3% during 2021-2026.
Major factors driving the growth of herbal supplement market size are, increase in the aging population, growing female buyers for dietary supplements, use of herbal products by young demography, and increasing consumer awareness for preventive healthcare measures.
Global Herbal Supplements and Remedies Market Trends
tmrFebruary 2, 2021
Global Herbal Supplements and Remedies Market: Overview
Herbs and plants are being extensively used for their medicinal properties since time immemorial. A large section of the global population is switching to herbal supplements due to their added health benefits. Herbal supplements or botanicals are natural non-pharmaceutical and non-food substances that are commercialized in the market to improve health.
The demand for herbal supplements is increasing due to their ‘natural’ label. Consumers are opting for herbal supplements to improve their health. Subsequently, increased prices of medicinal and dietary products have led to the growth of the global herbal supplements and remedies market.
To embed, copy and paste the code into your website or blog:
From contraceptives to mesh implants, shampoos to pasta, New York state and federal courts issued decisions in 2020 which further shaped the landscape in the medical and life sciences legal world. To prepare the best product liability and class action defense strategies for pharmaceuticals, medical devices and other FDA regulated products, it is often helpful to step back and review holdings that have affected the industry and may shape the year ahead.
In the
New York Medical and Life Sciences: Year in Review 2020, we review, analyze and share potential implications for future life science cases, based on several key judicial holdings in New York in 2020 pertaining to:
Applied DNA Promotes Judith Murrah to Chief Operating Officer
Applied DNA Promotes Judith Murrah to Chief Operating Officer
Applied DNA Sciences, Inc. (NASDAQ: APDN) (the Company), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, today announced the promotion of Chief Information Officer Judith Murrah to the role of Chief Operating Officer effective immediately. The promotion formalizes Ms. Murrahs expanding range of responsibilities that includes the development of key customer and partner relationships, QA oversight, and operations management. Ms. Murrah has been instrumental in the undertaking of capacity expansions for pooled COVID-19 surveillance testing at the Companys wholly-owned subsidiary, Applied DNA Clinical Laboratories, LLC, and for the ongoing implementation of Current Good Manufacturing Practices (cGMP) at LineaRx, a majority-owned subsidiary of the Company. The Company believes that the implementation of cGMP at LineaRx is necessary to respond t
Integrated cell-cum-gene therapy facility unveiled in Bengaluru
Kiran Mazumdar
Bengaluru– Immuneel Therapeutics Ltd, co-founded by Biocon chairperson Kiran Mazumdar-Shaw, unveiled its integrated cell-and-gene therapy development and manufacturing facility at Narayana Hrudayalaya Health City on the outskirts of this tech city on Monday.
“The research-led integrated facility has a hi-tech lab, CGMP-complaint manufacturing suites for cell and gene therapies to treat cancer patients from across the country,” said the city-based company in a statement here.
The Current Good Manufacturing Practices (CGMP) are required to conform to the guidelines recommended by agencies that control authorisation and licensing of the manufacture and sale of pharmaceutical products, dietary supplements and medical devices.